These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28754312)

  • 1. Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway.
    Churchill MJ; Pflibsen L; Sconce MD; Moore C; Kim K; Meshul CK
    Neuroscience; 2017 Sep; 359():224-247. PubMed ID: 28754312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson's Disease.
    Massaquoi MS; Liguore WA; Churchill MJ; Moore C; Melrose HL; Meshul CK
    Neuroscience; 2020 May; 433():53-71. PubMed ID: 32142862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.
    Klemann CJHM; Xicoy H; Poelmans G; Bloem BR; Martens GJM; Visser JE
    Mol Neurobiol; 2018 Jul; 55(7):5639-5657. PubMed ID: 29019056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson's Disease.
    Churchill MJ; Cantu MA; Kasanga EA; Moore C; Salvatore MF; Meshul CK
    Neuroscience; 2019 Aug; 414():8-27. PubMed ID: 31220543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
    Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
    Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism.
    Xu M; Bohlen JK; Moore C; Nipper MA; Finn DA; Jones CE; Lim MM; Meshul CK
    J Neurosci Res; 2019 Dec; 97(12):1706-1719. PubMed ID: 31535395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.
    Smith BA; Goldberg NR; Meshul CK
    Brain Res; 2011 Apr; 1386():70-80. PubMed ID: 21315689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Goldberg NR; Haack AK; Lim NS; Janson OK; Meshul CK
    Neuroscience; 2011 Apr; 180():256-71. PubMed ID: 21335067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease.
    Tillerson JL; Caudle WM; Reverón ME; Miller GW
    Neuroscience; 2003; 119(3):899-911. PubMed ID: 12809709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning.
    Goldberg NR; Hampton T; McCue S; Kale A; Meshul CK
    J Neurosci Res; 2011 Oct; 89(10):1698-706. PubMed ID: 21748776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
    O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
    Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
    Gil-Martínez AL; Cuenca L; Sánchez C; Estrada C; Fernández-Villalba E; Herrero MT
    J Neuroinflammation; 2018 Nov; 15(1):328. PubMed ID: 30477535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
    Breidert T; Callebert J; Heneka MT; Landreth G; Launay JM; Hirsch EC
    J Neurochem; 2002 Aug; 82(3):615-24. PubMed ID: 12153485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intermittent washout periods on progressive lesioning of the nigrostriatal pathway with 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Goldberg NR; Meshul CK
    Neuroscience; 2011 May; 182():203-7. PubMed ID: 21402128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.